Status:
COMPLETED
Electro-acupuncture for Central Obesity
Lead Sponsor:
Hong Kong Baptist University
Collaborating Sponsors:
Princess Margaret Hospital, Hong Kong
Conditions:
Central Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In this study, a 8-week, single blinded, randomized controlled clinical trial will be conducted to examine the efficacy and safety of body acupuncture in the treatment of central obesity in Hong Kong.
Detailed Description
This is a pilot single-blind, randomized, sham-controlled trial. 168 central obesity patients will be randomly assigned to acupuncture group or control group. The duration of the treatment will be 8 w...
Eligibility Criteria
Inclusion
- Patients who meet all of the following criteria are defined as eligible participants: men and women aged between 18 and 65 years old; BMI ≥ 25 kg/m2; central obesity, defined as WC of ≥ 90 cm in men and ≥ 80 cm in non-pregnant women according to ICD-10 \[24\]; not receiving any other weight control measures or any medical and/or drug history in last 3months.
Exclusion
- Patients who meet any of the following criteria should be excluded from the study: endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc.; heart diseases, including arrhythmia, heart failure, myocardial infarction, patients with pacemaker; allergy and immunology diseases; bleeding tendency; pregnant or lactating women; impaired hepatic or renal function; stroke or unable to exercise.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT03815253
Start Date
February 1 2019
End Date
February 28 2021
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Linda Zhong
Kowloon Tong, Kowloon, Hong Kong